Endothelial cell-matrix interactions in neovascularization

被引:66
|
作者
Francis, Megan E. [1 ,2 ,3 ]
Uriel, Shiri [1 ,2 ]
Brey, Eric M. [1 ,2 ,3 ]
机构
[1] IIT, Dept Biomed Engn, Chicago, IL 60616 USA
[2] IIT, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA
[3] Edward Hines Jr VA Hosp, Dept Res, Hines, IL 60141 USA
关键词
D O I
10.1089/teb.2007.0115
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The success of many therapies in regenerative medicine requires the ability to control the formation of stable vascular networks within tissues. The formation of new blood vessels, or neovascularization, is mediated, in part, by interactions between endothelial cells (ECs) and insoluble factors in the extracellular microenvironment. These interactions are determined by the chemical, physical, and mechanical properties of the matrix. Understanding how extracellular matrices (ECMs) and synthetic scaffolds influence neovascularization can contribute to the fundamental knowledge of normal and diseased tissue physiology and can be used to guide the design of new therapies. The goal of this review is to provide an overview of the complex role EC-matrix interactions play in neovascularization. A particular emphasis is placed on presenting differences in two subsets of ECM, basement membranes and stromal matrices, and identification of the properties of these matrices that define their biological functions. Attempts to apply information about EC-ECM interactions to enhance vascularization of synthetic materials are presented, and areas in need of further research are identified throughout this review. Our understanding of the role EC matrix interactions play in neovascularization remains limited, but continued progress in this area could be of significant benefit to the design of clinically applicable engineered tissues.
引用
收藏
页码:19 / 32
页数:14
相关论文
共 50 条
  • [41] Role of cell-matrix interactions in osteoclast differentiation
    McHugh, K. P.
    Shen, Z.
    Crotti, T. N.
    Flannery, M. R.
    Fajardo, R.
    Bierbaum, B. E.
    Goldring, S. R.
    OSTEOIMMUNOLOGY, 2007, 602 : 107 - 111
  • [42] The role of tissue transglutaminase in cell-matrix interactions
    Zemskov, EA
    Janiak, A
    Hang, J
    Waghray, A
    Belkin, AM
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 1057 - 1076
  • [43] CELL-MATRIX INTERACTIONS DURING TUMOR INVASION
    STARKEY, JR
    CANCER AND METASTASIS REVIEWS, 1990, 9 (02) : 113 - 123
  • [44] Cell-matrix interactions in temporomandibular joint homeostasis
    Reed, David A.
    FASEB JOURNAL, 2017, 31
  • [45] Mesangial cell-matrix interactions in glomerular inflammation
    Schoecklmann, HO
    Rupprecht, HD
    Gauer, S
    Yao, J
    Sterzel, RB
    KIDNEY & BLOOD PRESSURE RESEARCH, 1996, 19 (3-4): : 184 - 190
  • [46] Heparanase, a potential regulator of cell-matrix interactions
    Dempsey, LA
    Brunn, GJ
    Platt, JL
    TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (08) : 349 - 351
  • [47] ADAMs: modulators of cell-cell and cell-matrix interactions
    White, JM
    CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (05) : 598 - 606
  • [48] CHEMICAL ANALOGS OF THE EXTRACELLULAR-MATRIX - CELL-MATRIX INTERACTIONS
    YANNAS, IV
    ORGILL, DP
    MURPHY, GF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 175 - PMSE
  • [49] Extracellular matrix remodeling - Methods to quantify cell-matrix interactions
    Abraham, Leah C.
    Dice, J. Fred
    Finn, Patrick F.
    Mesires, Nicholas T.
    Lee, Kyongbum
    Kaplan, David L.
    BIOMATERIALS, 2007, 28 (02) : 151 - 161
  • [50] Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells
    Larsson, H
    Sjöblom, T
    Dixelius, J
    Östman, A
    Ylinenjärvi, K
    Björk, I
    Claesson-Welsh, L
    CANCER RESEARCH, 2000, 60 (23) : 6723 - 6729